Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Phillips 66 (PSX) Price & Performance

GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.

The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.

Phillips 66 (PSX) trades at $297.29, up 5.62% on the day, showing strong momentum near recent highs. The stock demonstrates solid fundamentals with a P/E of 16.71 and P/S of 0.78, while recent earnings beats and a 24.02% ROE highlight operational strength. Technical indicators show bullish momentum with the current price above key support levels. Recent news highlights structural advantages in refining margins and AI implementation for operational efficiency.

PSX presents a compelling investment case with strong profitability metrics and positive analyst sentiment (54% buy ratings), though current price exceeds the $286.90 consensus target. Key risks include refining margin volatility and potential policy impacts on diesel exports. The company's debt reduction progress and projected 2026 net cash flow of $3.0B support the bullish outlook despite competitive pressures.